These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24197824)

  • 1. Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control.
    Fronczyk A; Molęda P; Safranow K; Piechota W; Majkowska L
    Inflammation; 2014 Apr; 37(2):349-57. PubMed ID: 24197824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
    Streja D; Cressey P; Rabkin SW
    J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
    Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
    Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    J Diabetes Complications; 2019 Nov; 33(11):107413. PubMed ID: 31477553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ultrasensitive CRP and microalbuminuria as cardiovascular risk markers in type 2 diabetic moroccan patients.
    El Boukhrissi F; Benbella I; Ouleghzal H; Safi S; Bamou Y; Balouch L
    Tunis Med; 2017 Novembre; 95(11):982-987. PubMed ID: 29877557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of endothelial monocyte-activating polypeptide-II in type 2 diabetes mellitus].
    Mohyl'nyts'ka LA
    Fiziol Zh (1994); 2014; 60(1):84-90. PubMed ID: 24809179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
    Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
    Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study.
    Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A
    Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Bijelic R; Balaban J; Milicevic S; Sipka SU
    Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion.
    Bonaventura A; Liberale L; Carbone F; Scopinaro N; Camerini G; Papadia FS; Cordera R; Dallegri F; Adami GF; Montecucco F
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):423-429. PubMed ID: 28284664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
    Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
    Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes.
    Aljwaid H; White DL; Collard KJ; Moody AJ; Pinkney JH
    J Diabetes Complications; 2015; 29(7):943-9. PubMed ID: 26104728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes.
    Herrmann M; Sullivan DR; Veillard AS; McCorquodale T; Straub IR; Scott R; Laakso M; Topliss D; Jenkins AJ; Blankenberg S; Burton A; Keech AC;
    Diabetes Care; 2015 Mar; 38(3):521-8. PubMed ID: 25524951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome.
    Mavrakanas T; Frachebois C; Soualah A; Aloui F; Julier I; Bastide D
    Presse Med; 2009 Oct; 38(10):1399-403. PubMed ID: 19419831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
    Mohammedi K; Woodward M; Marre M; Colagiuri S; Cooper M; Harrap S; Mancia G; Poulter N; Williams B; Zoungas S; Chalmers J
    Cardiovasc Diabetol; 2017 Jul; 16(1):95. PubMed ID: 28750645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
    Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
    Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
    Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.